Wine and Olive Oil Phenolic Compounds Interaction in Humans
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Aldrich Raman
Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'- -
Current Disease-Targets for Oleocanthal As Promising Natural Therapeutic Agent
International Journal of Molecular Sciences Review Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent Antonio Segura-Carretero 1,2 and Jose Antonio Curiel 2,3,* 1 Department of Analytical Chemistry, University of Granada, 18071 Granada, Spain; [email protected] 2 Functional Food Research and Development Center, Health Science Technological Park, 18016 Granada, Spain 3 Torres Morente S.A.U., Bussines Park Metropolitano, 18130 Escúzar, Granada, Spain * Correspondence: [email protected]; Tel.: +34-958-637-206 Received: 5 September 2018; Accepted: 20 September 2018; Published: 24 September 2018 Abstract: The broad number of health benefits which can be obtained from the long-term consumption of olive oil are attributed mainly to its phenolic fraction. Many olive oil phenolics have been studied deeply since their discovery due to their bioactivity properties, such as Hydroxytyrosol. Similarly, in the last decade, the special attention of researchers has been addressed to Oleocanthal (OC). This olive oil phenolic compound has recently emerged as a potential therapeutic agent against a variety of diseases, including cancer, inflammation, and neurodegenerative and cardiovascular diseases. Recently, different underlying mechanisms of OC against these diseases have been explored. This review summarizes the current literature on OC to date, and focuses on its promising bioactivities against different disease-targets. Keywords: Oleocanthal; phenolic compounds; olive oil; therapeutic properties 1. Introduction The Mediterranean diet is characterized by a high consumption of olive oil, which plays a central role in the health benefits of the diet [1,2]. In fact, extra virgin olive oil (EVOO) in the Mediterranean region has long been associated with lower occurrences of certain chronic diseases, such as cancer incidence and cardiovascular mortality [3], as well as neurodegenerative dementias and Alzheimer disease [2–6]. -
Protein Suppresses Both Bitterness and Oleocanthal-Elicited Pungency
www.nature.com/scientificreports OPEN Protein suppresses both bitterness and oleocanthal‑elicited pungency of extra virgin olive oil Catherine Peyrot des Gachons1*, Abigail J. O’Keefe1, Louise Slade2 & Gary K. Beauchamp1 The Mediterranean diet, considered one of the healthiest in the world, is characterized in part by the major source of its fat, which is extra virgin olive oil (EVOO). Among the health benefts of consuming EVOOs is the presence of phenolic compounds, which have been shown to lower the incidence of coronary heart disease and are suspected of providing many other health benefts. These phenolic compounds also contribute to the favor of EVOO, adding both specifc pungency in the throat and bitter notes that are valued by connoisseurs but reported to be unpleasant by naïve consumers. Here, we demonstrate that some food‑derived proteins, specifcally from egg yolks and whey, when added to pungent and bitter EVOOs, reduce or even eliminate both the throat pungency and bitterness. The sensory loss is proportional to the food protein additions. Thus, when used in various foods recipes (e.g. mayonnaise), pungent and bitter EVOOs may lose their pungent and bitter characteristics thereby rendering them more palatable to many consumers. This sensory reduction might also indicate interaction between the proteins and the phenolic compounds, which, if confrmed, would raise the question of whether the bioactivities of EVOO phenolics remain unchanged when consumed with and without protein‑containing foods. Extra virgin olive oil (EVOO) is central to the Mediterranean diet, which is considered one of the healthiest in the world1. Te consumption of EVOO has been associated with many positive nutritional properties, including a well-established lower incidence of coronary heart disease 2–4. -
Green Route for the Isolation and Purification Of
molecules Article Green Route for the Isolation and Purification of Hyrdoxytyrosol, Tyrosol, Oleacein and Oleocanthal from Extra Virgin Olive Oil Antonio Francioso 1,* , Rodolfo Federico 2, Anna Maggiore 1, Mario Fontana 1 , Alberto Boffi 1,2, Maria D’Erme 1 and Luciana Mosca 1 1 Department of Biochemical Sciences, “Sapienza” University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy; [email protected] (A.M.); [email protected] (M.F.); alberto.boffi@uniroma1.it (A.B.); [email protected] (M.D.); [email protected] (L.M.) 2 MOLIROM s.r.l, via Carlo Bartolomeo Piazza 8, 00161 Rome, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-06-4991-0987 Academic Editors: Rafael Guillén Bejarano and María Rocío Rodríguez Arcos Received: 6 July 2020; Accepted: 10 August 2020; Published: 11 August 2020 Abstract: Extra virgin olive oil (EVOO) phenols represent a significant part of the intake of antioxidants and bioactive compounds in the Mediterranean diet. In particular, hydroxytyrosol (HTyr), tyrosol (Tyr), and the secoiridoids oleacein and oleocanthal play central roles as anti-inflammatory, neuro-protective and anti-cancer agents. These compounds cannot be easily obtained via chemical synthesis, and their isolation and purification from EVOO is cumbersome. Indeed, both processes involve the use of large volumes of organic solvents, hazardous reagents and several chromatographic steps. In this work we propose a novel optimized procedure for the green extraction, isolation and purification of HTyr, Tyr, oleacein and oleocanthal directly from EVOO, by using a Natural Deep Eutectic Solvent (NaDES) as an extracting phase, coupled with preparative high-performance liquid chromatography. -
Polyphenols and IUGR Pregnancies: Effects of the Antioxidant Hydroxytyrosol on Brain Neurochemistry and Development in a Porcine Model
antioxidants Article Polyphenols and IUGR Pregnancies: Effects of the Antioxidant Hydroxytyrosol on Brain Neurochemistry and Development in a Porcine Model Natalia Yeste 1 , Daniel Valent 1, Laura Arroyo 1, Marta Vázquez-Gómez 2 , Consolación García-Contreras 2, Martí Pumarola 3 , Antonio González-Bulnes 2,4,5 and Anna Bassols 1,* 1 Departament de Bioquímica i Biologia Molecular, Facultat de Veterinària, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain; [email protected] (N.Y.); [email protected] (D.V.); [email protected] (L.A.) 2 Faculty of Veterinary Sciences, UCM, Ciudad Universitaria s/n., 28040 Madrid, Spain; [email protected] (M.V.-G.); [email protected] (C.G.-C.); [email protected] (A.G.-B.) 3 Unitat de Patologia Murina i Comparada, Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain; [email protected] 4 Comparative Physiology Group, INIA, Avda, Puerta de Hierro s/n., 28040 Madrid, Spain 5 Departamento de Produccion y Sanidad Animal, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain * Correspondence: [email protected] Citation: Yeste, N.; Valent, D.; Arroyo, L.; Vázquez-Gómez, M.; Abstract: Supplementation of a mother’s diet with antioxidants, such as hydroxytyrosol (HTX), García-Contreras, C.; Pumarola, M.; has been proposed to ameliorate the adverse phenotypes of fetuses at risk of intrauterine growth González-Bulnes, A.; Bassols, A. restriction. In the present study, sows were treated daily with or without 1.5 mg of HTX per kilogram Polyphenols and IUGR Pregnancies: of feed from day 35 of pregnancy (at 30% of total gestational period), and individuals were sampled Effects of the Antioxidant Hydroxytyrosol on Brain at three different ages: 100-day-old fetuses and 1-month- and 6-month-old piglets. -
Nutraceuticals for Geriatrics
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Journal of Traditional and Complementary Medicine 5 (2015) 5e14 HOSTED BY Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier.com/locate/jtcme Review article Nutraceuticals for geriatrics * Charu Gupta , Dhan Prakash Amity Institute for Herbal Research & Studies, Amity University UP, Noida, India article info abstract Article history: Geriatrics is a medical practice that addresses the complex needs of older patients and emphasizes Received 7 May 2014 maintaining functional independence even in the presence of chronic disease. Treatment of geriatric Accepted 22 July 2014 patients requires a different strategy and is very complex. Geriatric medicines aim to promote health by Available online 17 December 2014 preventing and treating diseases and disabilities in older adults. Development of effective dietary in- terventions for promoting healthy aging is an active but challenging area of research because aging is Keywords: associated with an increased risk of chronic disease, disability, and death. Aging populations are a global aging phenomenon. The most widespread conditions affecting older people are hypertension, congestive heart geriatrics health failure, dementia, osteoporosis, breathing problems, cataract, and diabetes to name a few. Decreased nutraceutical immunity is also partially responsible for the increased morbidity and mortality resulting from infectious nutrition agents in the elderly. Nutritional status is one of the chief variables that explains differences in both the phytochemicals incidence and pathology of infection. Elderly people are at increased risk for micronutrient deficiencies due to a variety of factors including social, physical, economic, and emotional obstacles to eating. -
(12) United States Patent (10) Patent No.: US 9.446,006 B2 Fowler Et Al
USOO9446.006B2 (12) United States Patent (10) Patent No.: US 9.446,006 B2 FOWler et al. (45) Date of Patent: Sep. 20, 2016 (54) HYDROXYTYROSOL COMBINATIONS FOR A6II 3L/205 (2006.01) ENHANCING MITOCHONORAL FUNCTION A6II 3/44.15 (2006.01) AND ENERGY PRODUCTION A63L/455 (2006.01) A6II 3/74 (2006.01) (71) Applicants: Ann Fowler, Rheinfelden (CH): (Continued) Angelika Friedel, Binzen (DE); Darko (52) U.S. Cl. Knutti, Riehen (CH), Karin Kuratli, CPC .............. A61 K3I/05 (2013.01); A23K 20/III Reinach (CH), Daniel Raederstorff, (2016.05); A23K 20/121 (2016.05); A23K Flaxlanden (FR), Ying Wang-Schmidt, 20/147 (2016.05); A23K 20/174 (2016.05); Stallikon (CH), Karin Wertz, A2.3L I/296 (2013.01); A23L 1/30 (2013.01); Rheinfelden (DE) A2.3L I/3002 (2013.01); A23L I/302 (2013.01); A23L 1/3004 (2013.01); A23L (72) Inventors: Ann Fowler, Rheinfelden (CH): I/3051 (2013.01); A23L 2/52 (2013.01); A61 K Angelika Friedel, Binzen (DE); Darko 3 1/122 (2013.01); A61K 31/145 (2013.01); Knutti, Riehen (CH); Karin Kuratli, A61K 31/19 (2013.01); A61K 31/195 Reinach (CH); Daniel Raederstorff, (2013.01); A61K 31/197 (2013.01); A61 K Flaxlanden (FR); Ying Wang-Schmidt, 3 1/205 (2013.01); A61K 3 1/34 (2013.01); Stallikon (CH); Karin Wertz, A6 IK3I/352 (2013.01); A61K 31/4188 Rheinfelden (DE) (2013.01); A61 K3I/4406 (2013.01); A61 K 3 1/44.15 (2013.01); A61K 31/455 (2013.01); (73) Assignee: DSM IPASSETS B.V., Heerlen (NL) A6 IK3I/51 (2013.01); A61 K3I/522 (2013.01); A61 K3I/525 (2013.01); A61 K (*) Notice: Subject to any disclaimer, the term of this 3 1/714 (2013.01); A61K 36/63 (2013.01); patent is extended or adjusted under 35 A61K 45/06 (2013.01); A23 V 2002/00 U.S.C. -
Antioxidants
antioxidants Article Composition and Antioxidant Properties of Spanish Extra Virgin Olive Oil Regarding Cultivar, Harvest Year and Crop Stage Thays Helena Borges 1, Adriana Serna 2, Luis Carlos López 3 , Luis Lara 1, Rosa Nieto 1 and Isabel Seiquer 1,* 1 Departamento de Fisiología y Bioquímica de la Nutrición Animal, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas (CSIC), Camino del Jueves, Armilla, 18100 Granada, Spain 2 Policlínica de Especialidades Médicas. Federico Medrano 620, San Francisco del Rincón, Guanajuato 36300, Mexico; 3 Instituto de Biotecnología, Centro de Investigación Biomédica, Universidad de Granada, Avda. del Conocimiento, 18016 Granada, Spain * Correspondence: [email protected]; Tel.: +34-958-572-757; Fax: +34-958-572-753 Received: 25 June 2019; Accepted: 7 July 2019; Published: 11 July 2019 Abstract: The health benefits of extra virgin olive oil (EVOO) are related to its chemical composition and the presence of bioactive compounds with antioxidant properties. The aim of this study was to evaluate antioxidant compounds (pigments, coenzyme Q10 (CoQ10) and phenolic compounds) and antioxidant properties of EVOO from the same region comparing different cultivars (Hojiblanca and Arbequina), harvest year and crop stage. Antioxidant properties of oils were studied before and after a gastrointestinal digestion process, by in vitro assays (DPPH, ABTS and FRAP) and antioxidant markers in Caco-2 cells (reactive oxygen species production). The content of bioactive compounds measured was significantly affected by cultivar and harvest year (except for carotenoids) and by the crop stage (except for coenzyme Q10). Higher amounts of coenzyme Q10 were observed in Hojiblanca than in Arbequina EVOO. Total phenol content and antioxidant properties were also different depending on cultivar and harvest year and the in vitro digestion process strongly improved antioxidant marker values. -
Development and Validation of an Analytical Method for Quantification of Dopamine Metabolism in Plasma Samples by LC-MS/MS
Ana Sofia Abrantes Dias Development and validation of an analytical method for quantification of dopamine metabolism in plasma samples by LC-MS/MS Dissertação apresentada para provas de Mestrado em Química Forense Doutor Bruno José Fernandes Oliveira Manadas Professora Doutora Maria João Moreno junho 2017 Universidade de Coimbra Este projeto foi realizado no grupo Life Sciences Mass Spectrometry do Centro de Neurociências e Biologia Celular (Universidade de Coimbra, Portugal), orientado pelo Doutor Bruno Manadas. O trabalho foi financiado pela Fundação para a Ciência e Tecnologia (FCT), Portugal, com os projetos PTDC/SAU-NEU/103728/2008, PTDC/NEU-NMC/0205/2012, PTDC/NEU-SCC/7051/2014 e UID/NEU/04539/2013, e co-financiado pelo Programa COMPETE 2020 (Programa Operacional Fatores de Competitividade), pelo QREN, a União Europeia (FEDER – Fundo Europeu de Desenvolvimento Regional), e pela Rede Nacional de Espectrometria de Massa (RNEM), sob o contracto REDE/1506/REM/2005. The present work was performed in the Life Sciences Mass Spectrometry group of Center for Neuroscience and Cell Biology (University of Coimbra, Portugal), and under scientific guidance of Doctor Bruno Manadas. The work was supported by Fundação para a Ciência e Tecnologia (FCT), Portugal, projects references PTDC/SAU-NEU/103728/2008, PTDC/NEU-NMC/0205/2012, PTDC/NEU- SCC/7051/2014 and UID/NEU/04539/2013, and cofinanced by "COMPETE 2020 Programa Operacional Fatores de Competitividade, QREN, the European Union (FEDER – Fundo Europeu de Desenvolvimento Regional) and by The National Mass Spectrometry Network (RNEM) under contract REDE/1506/REM/2005. Agradecimentos A realização desta tese não teria sido possível sem o contributo, estímulo e empenho de várias pessoas e, como tal, gostaria de expressar toda a minha gratidão a todos os que, direta ou indiretamente contribuíram para que esta tarefa fosse possível. -
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: a Comprehensive Review
nutrients Review Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review Vincenzo Mollace 1,* , Giuseppe M. C. Rosano 2,3, Stefan D. Anker 4, Andrew J. S. Coats 3, Petar Seferovic 5, Rocco Mollace 1,6 , Annamaria Tavernese 1,6, Micaela Gliozzi 1, Vincenzo Musolino 1, Cristina Carresi 1, Jessica Maiuolo 1, Roberta Macrì 1, Francesca Bosco 1, Marcello Chiocchi 7, Francesco Romeo 8, Marco Metra 6 and Maurizio Volterrani 3 1 Department of Health Sciences, Institute of Research for Food Safety & Health, University “Magna Graecia” of Catanzaro, 88100 Catanzaro, Italy; [email protected] (R.M.); [email protected] (A.T.); [email protected] (M.G.); [email protected] (V.M.); [email protected] (C.C.); [email protected] (J.M.); [email protected] (R.M.); [email protected] (F.B.) 2 Cardiology Clinical Academic Group, St George’s Hospitals NHS Trust University of London, London SW17 0QT, UK; [email protected] 3 Department of Cardiology, IRCCS San Raffaele Pisana, 00166 Rome, Italy; [email protected] (A.J.S.C.); [email protected] (M.V.) 4 Department of Cardiology, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany; [email protected] 5 Faculty of Medicine, Belgrade University, 11000 Belgrade, Serbia; [email protected] 6 Department of Experimental and Applied Medicine, Institute of Cardiology, University of Brescia, 25121 Brescia, Italy; [email protected] 7 Department of Diagnostic Imaging and Interventional Radiology, -
De Novo Biosynthesis of Tyrosol Acetate and Hydroxytyrosol Acetate from Glucose in Engineered Escherichia Coli
De novo Biosynthesis of Tyrosol Acetate and Hydroxytyrosol Acetate from Glucose in Engineered Escherichia Coli Daoyi Guo ( [email protected] ) Gannan Normal University Xiao Fu Gannan Normal University Yue Sun Gannan Normal University Xun Li Gannan Normal University Hong Pan Gannan Normal University Research Keywords: Metabolic engineering, Escherichia coli, Tyrosol acetate, Hydroxytyrosol acetate, Posted Date: March 11th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-287007/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Background: Tyrosol and hydroxytyrosol derived from virgin olive oil and olives extract, have wide applications both as functional food components and as nutraceuticals. However, they have low bioavailability due to their low absorption and high metabolism in human liver and small intestine. Acetylation of tyrosol and hydroxytyrosol can effectively improve their bioavailability and thus increase their potential use in the food and cosmeceutical industries. There is no report on the bioproductin of tyrosol acetate and hydroxytyrosol acetate so far. Thus, it is of great signicance to develop microbial cell factories for achieving tyrosol acetate or hydroxytyrosol acetate biosynthesis. Results: In this study, two de novo biosynthetic pathways for the production of tyrosol acetate and hydroxytyrosol acetate were constructed in Escherichia coli. First, an engineered E. coli that allows production of tyrosol from simple carbon sources was established. Four aldehyde reductases were compared, and it was found that yeaE is the best aldehyde reductase for tyrosol accumulation. Subsequently, the pathway was extended for tyrosol acetate production by further overexpression of alcohol acetyltransferase ATF1 for the conversion of tyrosol to tyrosol acetate. -
SHORT COMMUNICATION Tyrosol and Hydroxytyrosol Are Absorbed from Moderate and Sustained Doses of Virgin Olive Oil in Humans
European Journal of Clinical Nutrition (2003) 57, 186–190 ß 2003 Nature Publishing Group All rights reserved 0954–3007/03 $25.00 www.nature.com/ejcn SHORT COMMUNICATION Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans E Miro´-Casas1, M-I Covas2, M Fito´ 2, M Farre´-Albadalejo1, J Marrugat2 and R de la Torre1 1Unitat de Recerca en Farmacologia, Institut Municipal d’Investigacio´ Me`dica, Barcelona, Spain; and 2Unitat de Lipids I Epidemiologia Cardiovascular, Institut Municipal d’Investigacio´ Me`dica, Barcelona, Spain Objective: To investigate the absorption of tyrosol and hydroxytyrosol from moderate and sustained doses of virgin olive oil consumption. The study also aimed to investigate whether these phenolic compounds could be used as biomarkers of virgin olive oil intake. Design and interventions: Ingestion of a single dose of virgin olive oil (50 ml). Thereafter, for a week, participants followed their usual diet which included 25 ml=day of the same virgin olive oil as the source of raw fat. Setting: Unitat de Recerca en Farmacologia. Institut Municipal d’Investigacio´ Me`dica (IMIM). Subjects: Seven healthy volunteers. Results: An increase in 24 h urine of tyrosol and hydroxytyrosol, after both a single-dose ingestion (50 ml) and short-term consumption (one week, 25 ml=day) of virgin olive oil (P < 0.05) was observed. Urinary recoveries for tyrosol were similar after a single dose and after sustained doses of virgin olive oil. Mean recovery values for hydroxytyrosol after sustained doses were 1.5- fold those obtained after a single 50 ml dose.